Objective: The aim of this study is to investigate the effects of the COVID-19 pandemic on the outcomes of patients operated for hip fractures, to determine the effect on mortality in the first postoperative year, and to compare with the pre-pandemic period.
Materials and methods: This retrospectively designed study included 291 patients who were operated on for hip fractures. The patients were divided into two groups as 134 patients admitted between 11 March-31 December 2019 (pre-COVID-19 period) and 157 patients admitted between 11 March-31 December 2020 (COVID-19 period). Age, gender, fracture type, implant used, smoking, operation waiting time, postoperative intensive care hospitalization, length of hospital stay, COVID-19 status, Charlson comorbidity index scores and mortality rates were evaluated from hospital records.
Results: Although there is an increase in mortality rates in the COVID-19 period, both in the postoperative one year and in the postoperative 30-day period, there is no statistically significant difference (p>0.05). Although the mortality rate of COVID-19 positive patients was higher in one year postoperatively than negative patients, it was shown that this difference was not statistically significant (p>0.05). In addition, it was determined that the mortality rates of COVID-19 positive patients in the postoperative 30-day period increased significantly compared to COVID-19 negatives (p=0.035).
Conclusion: Considering the one-year mortality rates in patients operated for hip fracture, mortality rates similar to those before the COVID-19 period were found. However, there is a strong correlation between COVID-19 positivity and high mortality outcomes, especially in the postoperative 30-day period.
Key words: Mortality; COVID-19; Pandemic; Hip fracture
|
